| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute for Nutrition Research (K.A.R.T., H.I.N.) Institute
of Medical Biochemistry (K.A.R.T., H.H.S., O.S., H.I.N.) Institute
of Basic Medical Sciences University of Oslo N-0316 Oslo,
Norway
Center for Biotechnology (S.A., J.-A.G.)
Department of Medical Nutrition Novum, S-141 86 Huddinge,
Sweden
Institut de Genetique et Biologie Moleculaire et
Cellulaire (J.A.) 67404 Illkirch, France
LXR
(liver X receptor, also called RLD-1) is a
nuclear receptor, highly expressed in tissues that play a role in lipid
homeostasis. In this report we show that fatty acids are positive
regulators of LXR
gene expression and we investigate the molecular
mechanisms underlying this regulation. In cultured rat hepatoma and
primary hepatocyte cells, fatty acids and the sulfur-substituted fatty
acid analog, tetradecylthioacetic acid , robustly induce LXR
(up to 3.5- and 7-fold, respectively) but not LXRß (also called OR-1)
mRNA steady state levels, with unsaturated fatty acids being more
effective than saturated fatty acids. RNA stability and nuclear run-on
studies demonstrate that changes in the transcription rate of the
LXR
gene account for the major part of the induction of LXR
mRNA
levels. A similar induction of protein level was also seen after
treatment of primary hepatocytes with the same fatty acids. Consistent
with such a transcriptional effect, transient transfection studies with
a luciferase reporter gene, driven by 1.5 kb of the 5'-flanking region
of the mouse (m)LXR
gene, show a peroxisome
proliferator-activated receptor-
-dependent increase in luciferase
activity upon treatment with tetradecylthioacetic acid and the
synthetic peroxisome proliferator-activated receptor-
activator, Wy
14.643, suggesting that the mLXR
5'-flanking region contains the
necessary sequence elements for fatty acid responsiveness. In addition,
in vivo LXR
expression was induced by fatty acids,
consistent with the in vitro cell culture data. These
observations demonstrate that LXR
expression is controlled by fatty
acid signaling pathways and suggest an important cross-talk between
fatty acid and cholesterol regulation of lipid metabolism.
This article has been cited by other articles:
![]() |
B. Herzog, M. Hallberg, A. Seth, A. Woods, R. White, and M. G. Parker The Nuclear Receptor Cofactor, Receptor-Interacting Protein 140, Is Required for the Regulation of Hepatic Lipid and Glucose Metabolism by Liver X Receptor Mol. Endocrinol., November 1, 2007; 21(11): 2687 - 2697. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Desvergne, L. Michalik, and W. Wahli Transcriptional Regulation of Metabolism Physiol Rev, April 1, 2006; 86(2): 465 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Radulescu, S. Lagarrigue, A. Siegel, P. Veber, and M. Le Borgne Topology and static response of interaction networks in molecular biology J R Soc Interface, February 22, 2006; 3(6): 185 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hu, P. Foxworthy, A. Siesky, J. V. Ficorilli, H. Gao, S. Li, M. Christe, T. Ryan, G. Cao, P. Eacho, et al. Hepatic Peroxisomal Fatty Acid {beta}-Oxidation Is Regulated by Liver X Receptor {alpha} Endocrinology, December 1, 2005; 146(12): 5380 - 5387. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Cheema, A. Agarwal-Mawal, C. M. Murray, and S. Tucker Lack of stimulation of cholesteryl ester transfer protein by cholesterol in the presence of a high-fat diet J. Lipid Res., November 1, 2005; 46(11): 2356 - 2366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Fernandez and K. L. West Mechanisms by which Dietary Fatty Acids Modulate Plasma Lipids1 J. Nutr., September 1, 2005; 135(9): 2075 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Kase, A. J. Wensaas, V. Aas, K. Hojlund, K. Levin, G. H. Thoresen, H. Beck-Nielsen, A. C. Rustan, and M. Gaster Skeletal Muscle Lipid Accumulation in Type 2 Diabetes May Involve the Liver X Receptor Pathway Diabetes, April 1, 2005; 54(4): 1108 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haugen, N. Zahid, K. T. Dalen, K. Hollung, H. I. Nebb, and C. A. Drevon Resistin expression in 3T3-L1 adipocytes is reduced by arachidonic acid J. Lipid Res., January 1, 2005; 46(1): 143 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Anderson, C. Dunn, A. Laughter, L. Yoon, C. Swanson, T. M. Stulnig, K. R. Steffensen, R. A.S. Chandraratna, J.-A. Gustafsson, and J. C. Corton Overlapping Transcriptional Programs Regulated by the Nuclear Receptors Peroxisome Proliferator-Activated Receptor {alpha}, Retinoid X Receptor, and Liver X Receptor in Mouse Liver Mol. Pharmacol., December 1, 2004; 66(6): 1440 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Ulven, K. T. Dalen, J.-A. Gustafsson, and H. I. Nebb Tissue-specific autoregulation of the LXR{alpha} gene facilitates induction of apoE in mouse adipose tissue J. Lipid Res., November 1, 2004; 45(11): 2052 - 2062. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Corton, U. Apte, S. P. Anderson, P. Limaye, L. Yoon, J. Latendresse, C. Dunn, J. I. Everitt, K. A. Voss, C. Swanson, et al. Mimetics of Caloric Restriction Include Agonists of Lipid-activated Nuclear Receptors J. Biol. Chem., October 29, 2004; 279(44): 46204 - 46212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kino and G. P. Chrousos Combating Atherosclerosis With LXR{alpha} And PPAR{alpha} Agonists: Is Rational Multitargeted Polypharmacy the Future of Therapeutics in Complex Diseases? Mol. Interv., October 1, 2004; 4(5): 254 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Beyer, R. J. Schmidt, P. Foxworthy, Y. Zhang, J. Dai, W. R. Bensch, R. F. Kauffman, H. Gao, T. P. Ryan, X.-C. Jiang, et al. Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-{alpha} Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Density Lipoprotein and Triglyceride Metabolism in Vivo J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 861 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Dalen, K. Schoonjans, S. M. Ulven, M. S. Weedon-Fekjaer, T. G. Bentzen, H. Koutnikova, J. Auwerx, and H. I. Nebb Adipose Tissue Expression of the Lipid Droplet-Associating Proteins S3-12 and Perilipin Is Controlled by Peroxisome Proliferator-Activated Receptor-{gamma} Diabetes, May 1, 2004; 53(5): 1243 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Seo, H. M. Moon, W. S. Kim, Y. S. Lee, H. W. Jeong, E. J. Yoo, J. Ham, H. Kang, M.-G. Park, K. R. Steffensen, et al. Activated Liver X Receptors Stimulate Adipocyte Differentiation through Induction of Peroxisome Proliferator-Activated Receptor {gamma} Expression Mol. Cell. Biol., April 15, 2004; 24(8): 3430 - 3444. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Steffensen and J.-A. Gustafsson Putative Metabolic Effects of the Liver X Receptor (LXR) Diabetes, February 1, 2004; 53(90001): S36 - 42. [Abstract] [Full Text] |
||||
![]() |
K. T. Dalen, S. M. Ulven, K. Bamberg, J.-A. Gustafsson, and H. I. Nebb Expression of the Insulin-responsive Glucose Transporter GLUT4 in Adipocytes Is Dependent on Liver X Receptor {alpha} J. Biol. Chem., November 28, 2003; 278(48): 48283 - 48291. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Knight, D. D. Patel, S. M. Humphreys, D. Wiggins, and G. F. Gibbons Inhibition of cholesterol absorption associated with a PPAR{alpha}-dependent increase in ABC binding cassette transporter A1 in mice J. Lipid Res., November 1, 2003; 44(11): 2049 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Borud, G. Mellgren, J. Lund, and M. Bakke Cloning and Characterization of a Novel Zinc Finger Protein that Modulates the Transcriptional Activity of Nuclear Receptors Mol. Endocrinol., November 1, 2003; 17(11): 2303 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Granlund, L. K. Juvet, J. I. Pedersen, and H. I. Nebb Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPAR{gamma} modulator J. Lipid Res., August 1, 2003; 44(8): 1441 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshikawa, T. Ide, H. Shimano, N. Yahagi, M. Amemiya-Kudo, T. Matsuzaka, S. Yatoh, T. Kitamine, H. Okazaki, Y. Tamura, et al. Cross-Talk between Peroxisome Proliferator-Activated Receptor (PPAR) {alpha} and Liver X Receptor (LXR) in Nutritional Regulation of Fatty Acid Metabolism. I. PPARs Suppress Sterol Regulatory Element Binding Protein-1c Promoter through Inhibition of LXR Signaling Mol. Endocrinol., July 1, 2003; 17(7): 1240 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Francis, J.-S. Annicotte, and J. Auwerx PPAR-{alpha} effects on the heart and other vascular tissues Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H1 - H9. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Z. Ruan, J. F. Moorhead, R. Fernando, D. C. Wheeler, S. H. Powis, and Z. Varghese PPAR Agonists Protect Mesangial Cells from Interleukin 1{beta}-Induced Intracellular Lipid Accumulation by Activating the ABCA1 Cholesterol Efflux Pathway J. Am. Soc. Nephrol., March 1, 2003; 14(3): 593 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Juvet, S. M. Andresen, G. U. Schuster, K. T. Dalen, K. A. R. Tobin, K. Hollung, F. Haugen, S. Jacinto, S. M. Ulven, K. Bamberg, et al. On the Role of Liver X Receptors in Lipid Accumulation in Adipocytes Mol. Endocrinol., February 1, 2003; 17(2): 172 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thomas, K. S. Bramlett, C. Montrose, P. Foxworthy, P. I. Eacho, D. McCann, G. Cao, A. Kiefer, J. McCowan, K.-l. Yu, et al. A Chemical Switch Regulates Fibrate Specificity for Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Versus Liver X Receptor J. Biol. Chem., January 17, 2003; 278(4): 2403 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Stulnig, K. R. Steffensen, H. Gao, M. Reimers, K. Dahlman-Wright, G. U. Schuster, and J.-A. Gustafsson Novel Roles of Liver X Receptors Exposed by Gene Expression Profiling in Liver and Adipose Tissue Mol. Pharmacol., December 1, 2002; 62(6): 1299 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Forcheron, A. Cachefo, S. Thevenon, C. Pinteur, and M. Beylot Mechanisms of the Triglyceride- and Cholesterol-Lowering Effect of Fenofibrate in Hyperlipidemic Type 2 Diabetic Patients Diabetes, December 1, 2002; 51(12): 3486 - 3491. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Uehara, T. Engel, Z. Li, C. Goepfert, S. Rust, X. Zhou, C. Langer, C. Schachtrup, J. Wiekowski, S. Lorkowski, et al. Polyunsaturated Fatty Acids and Acetoacetate Downregulate the Expression of the ATP-Binding Cassette Transporter A1 Diabetes, October 1, 2002; 51(10): 2922 - 2928. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Tangirala, E. D. Bischoff, S. B. Joseph, B. L. Wagner, R. Walczak, B. A. Laffitte, C. L. Daige, D. Thomas, R. A. Heyman, D. J. Mangelsdorf, et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis PNAS, September 3, 2002; 99(18): 11896 - 11901. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Ross, R. L. Erickson, I. Gerin, P. M. DeRose, L. Bajnok, K. A. Longo, D. E. Misek, R. Kuick, S. M. Hanash, K. B. Atkins, et al. Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor {alpha} in Adipocyte Metabolism Mol. Cell. Biol., August 15, 2002; 22(16): 5989 - 5999. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. L. Chiang Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors Endocr. Rev., August 1, 2002; 23(4): 443 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Stulnig, U. Oppermann, K. R. Steffensen, G. U. Schuster, and J.-A. Gustafsson Liver X Receptors Downregulate 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity Diabetes, August 1, 2002; 51(8): 2426 - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barbier, I. P. Torra, Y. Duguay, C. Blanquart, J.-C. Fruchart, C. Glineur, and B. Staels Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 717 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Borud, T. Hoang, M. Bakke, A. L. Jacob, J. Lund, and G. Mellgren The Nuclear Receptor Coactivators p300/CBP/Cointegrator-Associated Protein (p/CIP) and Transcription Intermediary Factor 2 (TIF2) Differentially Regulate PKA-Stimulated Transcriptional Activity of Steroidogenic Factor 1 Mol. Endocrinol., April 1, 2002; 16(4): 757 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and D. J. Mangelsdorf LuXuRies of Lipid Homeostasis: The Unity of Nuclear Hormone Receptors, Transcription Regulation, and Cholesterol Sensing Mol. Interv., April 1, 2002; 2(2): 78 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. R. Tobin, S. M. Ulven, G. U. Schuster, H. H. Steineger, S. M. Andresen, J.-A. Gustafsson, and H. I. Nebb Liver X Receptors as Insulin-mediating Factors in Fatty Acid and Cholesterol Biosynthesis J. Biol. Chem., March 15, 2002; 277(12): 10691 - 10697. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, C. Bolten, B. G. Bhat, J. Woodring-Dietz, S. Li, S. K. Prayaga, C. Xia, and D. S. Lala Induction of Human Liver X Receptor {alpha} Gene Expression Via an Autoregulatory Loop Mechanism Mol. Endocrinol., March 1, 2002; 16(3): 506 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Edwards, H. R. Kast, and A. M. Anisfeld BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis J. Lipid Res., January 1, 2002; 43(1): 2 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Laffitte, S. B. Joseph, R. Walczak, L. Pei, D. C. Wilpitz, J. L. Collins, and P. Tontonoz Autoregulation of the Human Liver X Receptor alpha Promoter Mol. Cell. Biol., November 15, 2001; 21(22): 7558 - 7568. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. J. Repa, K. Gauthier, and D. J. Mangelsdorf Regulation of Lipoprotein Lipase by the Oxysterol Receptors, LXRalpha and LXRbeta J. Biol. Chem., November 9, 2001; 276(46): 43018 - 43024. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Duplus, M. Glorian, and C. Forest Fatty Acid Regulation of Gene Transcription J. Biol. Chem., September 29, 2000; 275(40): 30749 - 30752. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |